Cambridge Cognition secures new £2.2 million contract

Cambridge Cognition Holdings Plc (LON:COG), which develops and markets digital solutions to assess brain health, has been selected as the cognitive assessment partner for a large at-home study.  The contract is valued at £2.2 million with revenue expected to be recognised by the Company over three years beginning in H2 2021.  This is the second, large, at-home cognitive testing contract the Company has secured in two months.  The previous one was announced on 8 April 2021 with a value of £0.5 million.

In delivering the contract, the Company will deploy web-based cognitive assessments (CANTABTM) monthly.  Cognition can fluctuate over the course of a day as well as over longer periods, therefore participants will be asked to periodically undertake short digital cognitive assessments up to three times a day.

Cambridge Cognition is uniquely positioned to secure this contract as its proprietary CANTAB™ cognitive assessments produce comparable performance whether delivered under supervision in clinics or unsupervised at home1,.  The Company also offers rapid assessments that have been validated for high-frequency testing on smartphones2

Matthew Stork, Chief Executive Officer of Cambridge Cognition, said:

“As widely predicted, the COVID-19 pandemic has accelerated interest in virtual clinical trial assessments and Cambridge Cognition is well positioned to benefit from the consequent substantial growth opportunities.  We are pleased to have secured another large contract for a virtual clinical trial where we will be working with a leading pharmaceutical company in the sector.  The Company has established a robust science foundation and an excellent customer service record and this combination continues be rewarded by securing contracts for the growing field of virtual clinical trials.”

References

1.        Backx R, Skirrow C, Dente P, Barnett JH, Cormack FK. Comparing Web-Based and Lab-Based Cognitive Assessment Using CANTAB™. J Med Internet Res 2020;22(8):e16792. doi: 10.2196/16792

2.        Allen L, Baker E, Thorp E et. Validation and Comparison of a Digital Digit Symbol Substitution (DSST) Task Performed on Smart Phones With a Traditional Paper-Pencil Version. Biological Psychiatry 2020; 88(9). DOI: https://doi.org/10.1016/j.biopsych.2021.02.342

Click to view all articles for the EPIC:
Or click to view the full company profile:
Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Cambridge Cognition Holdings

More articles like this

Cambridge Cognition Holdings

Cambridge Cognition growth in revenue of 50% to £4.5 million

Cambridge Cognition Holdings Plc (LON:COG), which develops and markets digital solutions to assess brain health, has announced a positive trading update for the six months ended 30 June 2021. The Company enjoyed a strong performance in the first half

Cambridge Cognition Holdings

Cambridge Cognition completes spin-out of Monument Therapeutics

Cambridge Cognition Holdings Plc (LON:COG), which develops and markets digital solutions to assess brain health, has announced the completion of the spin-out of Monument Therapeutics Limited, a drug development company applying digital phenotyping to central nervous system disorders.

Cambridge Cognition Holdings

Cambridge Cognition AGM to be held on 27 May 2021

Cambridge Cognition Holdings plc (LON:COG) which develops and markets digital solutions to assess brain health, has confirmed that the Annual Report and Accounts for the year ended 31 December 2020 and the Notice of the Annual General Meeting